Tech Company Financing Transactions
Avisi Technologies Funding Round
Avisi Technologies secured a $10.7 million Series A funding round on 2/25/2026. Investors included MedVenture Partners, 115K and Golden Seeds.
Transaction Overview
Company Name
Announced On
2/25/2026
Transaction Type
Venture Equity
Amount
$10,700,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1733 Woodside Rd 310
Redwood City, CA 94061
USA
Redwood City, CA 94061
USA
Phone
Undisclosed
Website
Email Address
Overview
Avisi Technologies was founded in 2017 through the University of Pennsylvania Y-Prize program. At the time, Avisi's founders dreamed of applying novel nanotechnologies to combat vision loss and prevent blindness. Through interdisciplinary efforts across materials science engineering and ophthalmology, the VisiPlate technology was born. With initial support from the President's Innovation Prize, National Science Foundation SBIR grants, MedTech Innovator, and more, Avisi accelerated its growth significantly. Today, Avisi's diverse and expert team remains committed to our mission to restore health and promote vitality. Together we'll create a world with accessible, cutting-edge healthcare solutions for all.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rui Jiang
Browse more venture capital transactions:
Prev: 2/25/2026: Myrias Optics venture capital transaction
Next: 2/25/2026: QazMoly venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs